# FORTIS (FORTIS) — Stock analysis

> Faxioms all-in-one stock review. Canonical page: https://faxioms.com/stocks/fortis

## Current market snapshot

- Exchange: NSE
- Country: India
- Price: ₹890.25
- Change: +0.47%
- As of: 2026-09-18
- 1D return: -0.01%
- 5D return: -1.82%
- 1M return: -3.36%
- Latest complete quarter: fy27_q1

## Faxioms Analysis

_As of 2026-09-18_

### Technical Outlook

As of September 18, 2026, Fortis is trading at ₹886.0, showing a mixed technical stance across timeframes. The daily timeframe indicates a bearish trend, with the price below key moving averages like the 20-day EMA (₹902.57) and 50-day SMA (₹926.83), and the Supertrend indicator also signaling bearish conditions. This is contrasted by the weekly timeframe, which shows a bullish Supertrend direction, although the price remains below its 20-day EMA (₹923.75) and 50-day SMA (₹905.07). The monthly timeframe also shows a bearish Supertrend, but the price is above the 20-day EMA (₹857.59) and 20-day SMA (₹859.88), suggesting some underlying strength on a longer-term view.

Nearest support is observed at the pivot level of ₹885.82, approximately 0.02% below the current price. Further support lies at ₹877.96. Resistance is noted around ₹897.28, about 1.27% higher, followed by ₹908.47. The stock has experienced 2 downside events in the past 30 days out of a total of 6 market events. Volatility is indicated by an annualized volatility of 29% and an Average True Range (ATR) of 2.16% of the current price. The maximum drawdown observed is -28%. Active daily patterns include a Doji and a Harami formation as of September 18, 2026.

Key conditions to watch include a break below the ₹885.82 support level, which could signal further downside. Conversely, a sustained move above the nearest resistance at ₹897.28, and subsequently ₹908.47, would be needed to challenge the prevailing bearish daily trend. The divergence between the daily and weekly Supertrend signals warrants close observation for potential trend confirmation or reversal.

- Current price as of September 18, 2026: ₹886.0
- Nearest support level: ₹885.82 (approx. 0.02% below current price)
- Nearest resistance level: ₹897.28 (approx. 1.27% above current price)
- Daily timeframe shows a bearish trend with price below key moving averages.
- Weekly timeframe shows a bullish Supertrend direction, contrasting the daily view.
- Active daily patterns include Doji and Harami formations as of September 18, 2026.

- Doji
- Harami
- Bullish Engulfing Reversal
- Bearish Engulfing Reversal
- Evening Star

### News Context

Fortis Healthcare experienced a notable share price increase on September 17, 2026, following the announcement of a significant long-term agreement. The company signed definitive agreements with Seth Sunder Lal Jain Charitable Eye Hospital for healthcare services, a deal spanning 29 years. This development led to Fortis Healthcare shares climbing over 3% in early trading, reaching ₹895.85. In parallel, Fortis has also initiated legal proceedings by filing an appeal in the Supreme Court, a move that follows a Delhi High Court order, indicating ongoing legal complexities.

The broader market saw the S&P BSE Sensex gain 281.77 points, or 0.38%, to 74,618.22, and the Nifty 50 index add 128.70 points, or 0.55%, to 23,346.30 by 12:25 IST on September 17, 2026.

- On September 17, 2026, Fortis Healthcare shares rose over 3% after signing a 29-year healthcare services agreement with Seth Sunder Lal Jain Charitable Eye Hospital.
- The company's share price reached ₹895.85 following the announcement of the agreement.
- Fortis Healthcare filed an appeal in the Supreme Court on September 17, 2026, concerning a protracted legal battle.
- The S&P BSE Sensex increased by 0.38% and the Nifty 50 index by 0.55% on September 17, 2026.

- Fortis moves Supreme Court against Delhi High Court order
- Sensex gains 282 pts; metal shares advance
- Fortis Healthcare shares rise over 3% in early deals; here's why
- Fortis Healthcare climbs after signing 29-year healthcare services agreement
- Stock Alert: Tempsens Instruments India, Infosys, Highway Infra, Alembic Pharma

### What Changed

On September 18, 2026, Fortis Healthcare (NSE: FORTIS) saw a minor price change, closing at ₹886.0 compared to ₹886.1 on the previous day. In recent news, the company has filed an appeal in the Supreme Court concerning an order from the Delhi High Court, adding a new development to the ongoing legal matter involving Daiichi Sankyo. This legal action represents a recent shift in the company's engagement with this protracted dispute.

- On 2026-09-18, Fortis Healthcare's closing price was ₹886.0.
- The closing price on 2026-09-17 was ₹886.1.
- Fortis Healthcare filed an appeal in the Supreme Court on or before 2026-09-18, related to a Delhi High Court order.

- Fortis moves Supreme Court against Delhi High Court order

### Official Filings

Fortis Healthcare Limited's subsidiary, Fortis Hospotel Limited, has entered into significant agreements to provide healthcare services and a loan for a new super specialty hospital in Ashok Vihar, New Delhi. This development involves a 29-year Healthcare Services Agreement with Seth Sunder Lal Jain Charitable Eye Hospital (SLJ Society), under which Fortis Hospotel will operate clinical services. Additionally, Fortis will provide a phased loan of up to ₹567 crore to SLJ Society for the hospital's construction and operation, with the hospital expected to commence operations in 3-4 years. Separately, Fortis Healthcare has filed a Special Leave Petition with the Supreme Court of India on September 16, 2026, challenging a Delhi High Court judgment related to a case involving Daiichi Sankyo Company, Limited. The company has stated that this petition has no expected financial implications or quantum of claims.

In other developments, Fortis Healthcare has scheduled investor meetings, including a Non-Deal Roadshow organized by BNP Paribas on September 21, 2026, and participation in a J.P. Morgan India Conference on September 22, 2026, both in Mumbai. These meetings are intended for discussions with analysts and institutional investors, with no unpublished price-sensitive information to be shared.

- On September 16, 2026, Fortis Hospotel Limited signed a 29-year Healthcare Services Agreement and a Loan Agreement with SLJ Society for a new 400+ bedded super specialty hospital in Ashok Vihar, New Delhi.
- Fortis Hospotel Limited will provide a loan of up to ₹567 crore, disbursed over 3-4 years, for the hospital's construction and operation.
- The new hospital is expected to commence operations within 3-4 years, subject to necessary approvals.
- On September 16, 2026, Fortis Healthcare Limited filed a Special Leave Petition with the Supreme Court of India concerning a prior judgment, stating no expected financial implications.
- Fortis Healthcare Limited is scheduled for investor meetings on September 21 and September 22, 2026, in Mumbai.

- Fortis Healthcare Limited has informed the Exchange about filing of Special Leave Petition ( SLP ) before the Hon ble Supreme Court of India |SUBJECT: General Updates
- Fortis Healthcare Limited has informed the Exchange about Signing the Definitive Agreements by Fortis Hospotel Limited (wholly owned subsidiary of the Company) to provide Healthcare Services to a 400+ bedded Super Specialty Hospital in Ashok Vihar, New Delhi |SUBJECT: General Updates
- Fortis Healthcare Limited has informed the Exchange regarding a press release dated September 16, 2026, titled "Fortis Signs Definitive Agreements to provide Healthcare Services to a 400+ bedded Super Specialty Hospital in Ashok Vihar, New Delhi". |SUBJECT: Press Release
- Fortis Healthcare Limited has informed the Exchange about Signing of Definitive Agreements by Fortis Hospotel Limited (wholly owned subsidiary of the Company) to provide Healthcare Services to a 400+ bedded Super Specialty Hospital in Ashok Vihar, New Delhi |SUBJECT: Arrangements for strategic, technical, manufacturing, or marketing tie up
- Fortis Healthcare Limited has informed the Exchange about Arrangements (Sub-para 2-Para B) |SUBJECT: Arrangements (Sub-para 2-Para B)
- Fortis Healthcare Limited has informed the Exchange about Schedule of meet |SUBJECT: Analysts/Institutional Investor Meet/Con. Call Updates
- Fortis Healthcare Limited has informed the Exchange about Schedule of Analysts or Institutional Investors Meet |SUBJECT: Analyst/Investor Meet Para A-XBRL
- Fortis Healthcare Limited has informed the Exchange about General Updates |SUBJECT: General Updates

### Fundamentals

Fortis Healthcare has demonstrated a consistent upward trend in its operating performance, with sales growing from ₹6,893 crore in FY2024 to an estimated ₹9,128 crore by FY2026. This revenue growth is accompanied by an expansion in operating profit, projected to increase from ₹1,268 crore in FY2024 to ₹2,085 crore by FY2026. The operating profit margin (OPM) is also expected to improve, rising from 18% in FY2024 to an estimated 23% by FY2026. Net profit has shown significant growth, from ₹645 crore in FY2024 to a projected ₹1,064 crore by FY2026, with Earnings Per Share (EPS) anticipated to grow from ₹7.93 in FY2024 to ₹13.80 by FY2026.

The company's balance sheet shows a reduction in borrowings from ₹1,155 crore in March 2024 to an estimated ₹3,473 crore by March 2026, though this is projected to increase significantly. Equity capital has remained stable at ₹755 crore. Fixed assets have grown from ₹9,874 crore in March 2024 to an estimated ₹12,230 crore by March 2026, indicating investment in infrastructure. Cash flow from operations has been robust, increasing from ₹1,100 crore in FY2024 to an estimated ₹1,601 crore by FY2026. Free cash flow is also projected to improve, from ₹172 crore in FY2024 to ₹673 crore by FY2026.

Key monitoring areas include the projected increase in borrowings to ₹3,473 crore by March 2026 and the associated finance costs, which are estimated to rise from ₹131 crore in FY2024 to ₹314 crore by FY2026. The company's dividend payout ratio is expected to decrease from 13% in FY2024 to 7% by FY2026. Changes in the shareholding patterns, particularly the movements of Domestic Institutional Investors (DIIs) and Foreign Institutional Investors (FIIs), will be important to observe.

- Sales are projected to grow from ₹6,893 crore in FY2024 to ₹9,128 crore by FY2026.
- Operating Profit is expected to increase from ₹1,268 crore in FY2024 to ₹2,085 crore by FY2026, with OPM rising from 18% to 23%.
- Net Profit is projected to grow from ₹645 crore in FY2024 to ₹1,064 crore by FY2026, with EPS reaching ₹13.80.
- Borrowings are projected to increase from ₹1,155 crore in March 2024 to ₹3,473 crore by March 2026.
- Finance costs are estimated to rise from ₹131 crore in FY2024 to ₹314 crore by FY2026.

### Bull Case

Fortis Healthcare has demonstrated positive sales and profit growth over the past five years, with compounded annual growth rates of 18% for sales and 64% for profit. This growth trend continued on a trailing twelve months (TTM) basis, with sales growing at 18% and profit at 16%. The company has also made progress in reducing its debt, with borrowings decreasing from ₹2,010 crore in March 2019 to ₹1,594 crore in March 2020. Furthermore, cash flow from operations has shown improvement, with CFO/OP increasing to 84.0 in March 2020 from 30.0 in March 2019, and operating cash flow turning positive at ₹172 crore in March 2020 compared to a negative ₹179 crore in March 2019. The company also reported positive free cash flow of ₹35 crore in March 2020, a significant improvement from a negative ₹261 crore in March 2019. A recent development includes a 29-year healthcare services agreement signed with Seth Sunder Lal Jain Charitable Eye Hospital, which could support future operations.

- Compounded sales growth of 18% over 5 years and TTM.
- Compounded profit growth of 64% over 5 years and 16% TTM.
- Borrowings reduced from ₹2,010 crore (Mar 2019) to ₹1,594 crore (Mar 2020).
- Cash Flow from Operations (CFO/OP) improved to 84.0 (Mar 2020) from 30.0 (Mar 2019).
- Operating Cash Flow turned positive to ₹172 crore (Mar 2020) from ₹-179 crore (Mar 2019).
- Free Cash Flow improved to ₹35 crore (Mar 2020) from ₹-261 crore (Mar 2019).
- Signed a 29-year healthcare services agreement with Seth Sunder Lal Jain Charitable Eye Hospital.

- Fortis moves Supreme Court against Delhi High Court order
- Sensex gains 282 pts; metal shares advance
- Fortis Healthcare shares rise over 3% in early deals; here's why
- Fortis Healthcare climbs after signing 29-year healthcare services agreement
- Stock Alert: Tempsens Instruments India, Infosys, Highway Infra, Alembic Pharma

### Bear Case

Fortis Healthcare's balance sheet shows a reduction in borrowings from ₹2,010 crore in March 2019 to ₹1,594 crore in March 2020. However, this was accompanied by a decrease in cash from financing activities, which fell from ₹4,257 crore in March 2019 to a negative ₹862 crore in March 2020. The company also experienced a decline in total assets from ₹11,486 crore in March 2019 to ₹11,036 crore in March 2020, with a corresponding decrease in total liabilities. Cash flow from investing activities also shifted from a negative ₹3,279 crore in March 2019 to a positive ₹63 crore in March 2020, while free cash flow improved from a negative ₹261 crore to a positive ₹35 crore over the same period. Technical indicators suggest a bearish trend on the daily and monthly timeframes, with the Supertrend indicator pointing to a bearish direction on both. The stock is trading below its 20-day and 50-day moving averages on the daily chart.

- Borrowings decreased by ₹416 crore from ₹2,010 crore (Mar 2019) to ₹1,594 crore (Mar 2020).
- Cash from financing activities turned negative, decreasing from ₹4,257 crore (Mar 2019) to -₹862 crore (Mar 2020).
- Total assets declined by ₹450 crore from ₹11,486 crore (Mar 2019) to ₹11,036 crore (Mar 2020).
- Daily and monthly Supertrend indicators show a bearish direction as of 2026-09-18.

- Fortis moves Supreme Court against Delhi High Court order
- Sensex gains 282 pts; metal shares advance
- Fortis Healthcare shares rise over 3% in early deals; here's why
- Fortis Healthcare climbs after signing 29-year healthcare services agreement
- Stock Alert: Tempsens Instruments India, Infosys, Highway Infra, Alembic Pharma

### FAQs

**What is the nature of the recent agreement signed by Fortis Healthcare's subsidiary in Ashok Vihar, New Delhi?**

On September 16, 2026, Fortis Hospotel Limited, a wholly owned subsidiary of Fortis Healthcare, signed definitive agreements with Seth Sunder Lal Jain Charitable Eye Hospital. This agreement allows Fortis Hospotel to provide healthcare services for a new 400+ bedded super specialty hospital in Ashok Vihar, New Delhi. The arrangement includes a 29-year Healthcare Services Agreement where Fortis Hospotel will have exclusive rights to provide specified inpatient services and specialized equipment. Additionally, Fortis will provide a loan of up to ₹567 crore, disbursed over 3-4 years, to the Seth Sunder Lal Jain Charitable Eye Hospital for the hospital's construction and operation. The hospital is expected to commence operations within 3-4 years, subject to necessary approvals.

**What is the company's current legal situation regarding the Supreme Court filing?**

On September 16, 2026, Fortis Healthcare Limited informed the exchange about filing a Special Leave Petition before the Supreme Court of India. This filing challenges a Delhi High Court judgment dated August 31, 2026, related to a case involving Daiichi Sankyo Company, Limited. The company has disclosed that this petition has no expected financial implications or specified quantum of claims.

**How have Fortis Healthcare's key balance sheet items changed between March 2019 and March 2020?**

Between March 2019 and March 2020, Fortis Healthcare saw a reduction in its Borrowings from ₹2,010 crore to ₹1,594 crore. Capital Work In Progress (CWIP) decreased from ₹450 crore to ₹204 crore, and Investments fell from ₹270 crore to ₹175 crore. Other Assets also reduced from ₹2,290 crore to ₹1,856 crore. Total Assets decreased from ₹11,486 crore to ₹11,036 crore. Equity Capital remained constant at ₹755 crore, while Reserves increased slightly from ₹5,846 crore to ₹5,906 crore. Total Liabilities decreased from ₹11,486 crore to ₹11,036 crore.

**What has been the trend in Fortis Healthcare's cash flow from operations and free cash flow?**

Fortis Healthcare's cash flow from operating activities improved significantly, moving from a negative ₹179 crore in March 2019 to a positive ₹172 crore in March 2020. Correspondingly, Free Cash Flow improved from a negative ₹261 crore in March 2019 to a positive ₹35 crore in March 2020. The Cash from Financing Activity decreased from ₹4,257 crore in March 2019 to a negative ₹862 crore in March 2020, and Cash from Investing Activity shifted from a negative ₹3,279 crore in March 2019 to a positive ₹63 crore in March 2020. Net Cash Flow was ₹799 crore in March 2019 and turned negative at ₹627 crore in March 2020.

**What are the recent short-term and long-term sales and profit growth rates for Fortis Healthcare?**

Fortis Healthcare has demonstrated a Compounded Sales Growth of 18% over the last 5 years and also for the Trailing Twelve Months (TTM). For profits, the Compounded Profit Growth has been 64% over the last 5 years and 16% for the TTM period.

- Fortis moves Supreme Court against Delhi High Court order
- Sensex gains 282 pts; metal shares advance
- Fortis Healthcare shares rise over 3% in early deals; here's why
- Fortis Healthcare climbs after signing 29-year healthcare services agreement
- Stock Alert: Tempsens Instruments India, Infosys, Highway Infra, Alembic Pharma
- Fortis Healthcare Limited has informed the Exchange about filing of Special Leave Petition ( SLP ) before the Hon ble Supreme Court of India |SUBJECT: General Updates
- Fortis Healthcare Limited has informed the Exchange about Signing the Definitive Agreements by Fortis Hospotel Limited (wholly owned subsidiary of the Company) to provide Healthcare Services to a 400+ bedded Super Specialty Hospital in Ashok Vihar, New Delhi |SUBJECT: General Updates
- Fortis Healthcare Limited has informed the Exchange regarding a press release dated September 16, 2026, titled "Fortis Signs Definitive Agreements to provide Healthcare Services to a 400+ bedded Super Specialty Hospital in Ashok Vihar, New Delhi". |SUBJECT: Press Release
- Fortis Healthcare Limited has informed the Exchange about Signing of Definitive Agreements by Fortis Hospotel Limited (wholly owned subsidiary of the Company) to provide Healthcare Services to a 400+ bedded Super Specialty Hospital in Ashok Vihar, New Delhi |SUBJECT: Arrangements for strategic, technical, manufacturing, or marketing tie up
- Fortis Healthcare Limited has informed the Exchange about Arrangements (Sub-para 2-Para B) |SUBJECT: Arrangements (Sub-para 2-Para B)
## Technical analytics

- As of: 2026-09-18
- Daily trend: Weak Downtrend
- Weekly trend: Weak Downtrend
- Pivot point: ₹885.82
- Risk regime: Price Risk Requires Attention

### Support levels
- 877.9625000000001
- 847.66875
- 827.3

### Resistance levels
- 918.4
- 950.45
- 981.43359375

### Return and range metrics

| Metric | Value |
| --- | --- |
| return_1 | -0.01% |
| return_10 | -3.43% |
| return_1m | -3.35% |
| return_1y | -8.51% |
| return_20 | -3.36% |
| return_3m | -7.59% |
| return_5 | -1.82% |
| return_6m | +4.73% |
| return_since_start | +25.05% |
| return_ytd | -1.62% |

### Risk and volatility metrics

| Metric | Value |
| --- | --- |
| state | elevated_risk |
| label | Price risk requires attention |
| summary | Recent drawdown or price variability is high enough to warrant closer monitoring. |
| maximum_drawdown | -28.16% |
| annualized_volatility | +28.69% |

## Quarterly financials

- Latest complete quarter: fy27_q1

# Revenue Growth Accelerates, but Profit Growth Lags as Tax Expense Normalises

Fortis Healthcare reported a 17.5% year-on-year increase in revenue for the June 2026 quarter, reaching ₹2,545 crore. However, profit before tax rose only 3.2% over the same period, and net profit was essentially flat. The quarter’s main financial story is one of top-line momentum that did not flow through to the bottom line at the same rate, partly because of a sharp sequential increase in tax expense.

## Revenue: Sustained Sequential and Annual Growth

Revenue from operations rose to ₹2,545 crore in the June 2026 quarter, up 7.6% from the preceding March 2026 quarter (₹2,365 crore) and 17.5% from the year-ago June 2025 quarter (₹2,167 crore). This is the highest quarterly revenue in the last five fiscal quarters, continuing a trend where revenue increased in three of the last four quarter-on-quarter comparisons. The sequential growth accelerated from 4.4% in the March quarter to 7.6% in the June quarter.

## Profitability: Revenue Growth Outpaces Profit Growth

Profit before tax (PBT) increased 12.8% sequentially to ₹359 crore, but the year-on-year comparison showed only a 3.2% rise from ₹348 crore. Finance costs increased 15.6% year-on-year to ₹80 crore, a pace close to revenue growth.

Net profit (profit for the period) was ₹273 crore, nearly unchanged from ₹271 crore in the March 2026 quarter and only 2.3% above ₹267 crore a year ago. Basic earnings per share stood at ₹3.53, compared with ₹3.52 in the previous quarter and ₹3.45 a year earlier.

## Tax Expense: A Major Sequential Swing

Tax expense jumped 70.5% sequentially from ₹53 crore in the March 2026 quarter to ₹90 crore in the June 2026 quarter. The March quarter figure was the lowest in the last five quarters, making the sequential rise particularly large. On a year-on-year basis, tax expense rose 7.9% from ₹84 crore.

The effective tax rate for the quarter was approximately 25.2% (₹90 crore on PBT of ₹359 crore), up from 16.7% in the March quarter and returning closer to the 24.1% recorded in the same quarter last year. This increase absorbed most of the sequential gain in profit before tax, leaving net profit nearly flat.

## Segment Performance: Consolidated and Segment Figures Align Closely

Segment revenue from operations matched the consolidated revenue of ₹2,545 crore, indicating that all revenue is attributed to reportable segments. Segment profit before tax was ₹363 crore, slightly above the consolidated PBT of ₹359 crore. The difference of approximately ₹4 crore likely reflects unallocated corporate expenses or eliminations, consistent with the pattern in prior quarters (e.g., March 2026: segment PBT ₹324 crore vs. consolidated ₹318 crore).

The segment PBT margin (segment PBT / segment revenue) was 14.3%, down from 16.2% a year earlier, though higher than the 13.7% recorded in the March quarter. The year-on-year margin compression mirrors the trend observed at the consolidated level.

## Key Takeaway

Fortis Healthcare delivered broad-based revenue growth in the June 2026 quarter, but the benefit did not translate into a proportionate increase in net profit. Profit before tax grew modestly year on year, and net profit was essentially flat as a higher tax expense absorbed the sequential improvement in PBT. The divergence between top-line growth and bottom-line performance was driven by a normalisation of the effective tax rate after a low March quarter and by the fact that profit before tax grew at a much slower pace than revenue.

### Ratios

## Official filings

- 2026-09-16 — Generic Announcement: Fortis Healthcare Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/FORTIS_16092026110234_final.pdf)
- 2026-09-16 — Generic Announcement: Fortis Healthcare Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/FORTIS_16092026191152_FINAL.pdf)
- 2026-09-16 — Press Release: Fortis Healthcare Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/FORTIS_16092026191403_FINAL.pdf)
- 2026-09-16 — Generic Announcement: Fortis Healthcare Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/FORTIS_16092026192102_FINAL.pdf)
- 2026-09-16 — Generic Announcement: Fortis Healthcare Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/xbrl/REG30_PARA_B_2587_WebXMLFile_20260916_193406277.xml)
- 2026-09-15 — Generic Announcement: Fortis Healthcare Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/FORTIS_15092026183531_intimationroadshow.pdf)
- 2026-09-15 — Generic Announcement: Fortis Healthcare Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/FORTIS_15092026183647_intimationroadshow.pdf)
- 2026-09-15 — Generic Announcement: Fortis Healthcare Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/xbrl/SAIIM_2587_WebXMLFile_20260915_190716407.xml)
- 2026-09-15 — Generic Announcement: Fortis Healthcare Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/xbrl/SAIIM_2587_WebXMLFile_20260915_190625186.xml)
- 2026-09-11 — Generic Announcement: Fortis Healthcare Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/FORTIS_11092026124529_final.pdf)
- 2026-09-10 — Generic Announcement: Fortis Healthcare Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/FORTIS_10092026152127_IntimationFinal.pdf)
- 2026-09-09 — Generic Announcement: Fortis Healthcare Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/xbrl/SAIIM_2587_WebXMLFile_20260909_191852513.xml)
- 2026-09-09 — Generic Announcement: Fortis Healthcare Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/xbrl/SAIIM_2587_WebXMLFile_20260909_192037869.xml)
- 2026-09-09 — Generic Announcement: Fortis Healthcare Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/FORTIS_09092026192946_intimation.pdf)
- 2026-09-09 — Generic Announcement: Fortis Healthcare Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/FORTIS_09092026192812_intimation.pdf)
- 2026-09-09 — Generic Announcement: Fortis Healthcare Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/FORTIS_09092026234831_IntimationRevised.pdf)
- 2026-09-09 — Generic Announcement: Fortis Healthcare Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/FORTIS_09092026234636_IntimationRevised.pdf)
- 2026-09-04 — Generic Announcement: Fortis Healthcare Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/xbrl/SAIIM_2587_WebXMLFile_20260904_173513353.xml)
- 2026-09-04 — Generic Announcement: Fortis Healthcare Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/FORTIS_04092026173302_FHLintimation.pdf)
- 2026-09-01 — Generic Announcement: Fortis Healthcare Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/FORTIS_01092026193652_FHLIntimation.pdf)
- 2026-09-01 — Generic Announcement: Fortis Healthcare Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/xbrl/SAIIM_2587_WebXMLFile_20260901_195844382.xml)
- 2026-08-31 — Generic Announcement: Fortis Healthcare Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/FORTIS_01092026003656_Intimation.pdf)
- 2026-08-24 — Generic Announcement: Fortis Healthcare Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/FORTIS_24082026195407_final.pdf)
- 2026-08-21 — Generic Announcement: Fortis 01 2026 — [Official attachment](https://nsearchives.nseindia.com/content/debt/WDM/Fortis2026_21082026134740_PayoutReport_FORTIS_AUG_2026.pdf)
- 2026-08-11 — Management Change: Fortis Healthcare Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/FORTIS_11082026205640_fhlvotingresult.pdf)

## News and market events

- 2026-09-17 — Times of India: **Fortis moves Supreme Court against Delhi High Court order** — India Business News: In another twist to the protracted battle against Fortis Healthcare and Japan’s Daiichi Sankyo, the former has filed an appeal in the Supreme Court ag. — [Source](https://timesofindia.indiatimes.com/business/india-business/fortis-moves-supreme-court-against-delhi-high-court-order/articleshow/134309495.cms)
- 2026-09-17 — BUSINESS: **Sensex gains 282 pts; metal shares advance** — At 12:25 IST, the barometer index, the S&P BSE Sensex jumped 281.77 points or 0.38% to 74,618.22. The Nifty 50 index added 128.70 points or 0.55% to 23,346.30. — [Source](https://www.business-standard.com/markets/capital-market-news/sensex-gains-282-pts-metal-shares-advance-126091700462_1.html)
- 2026-09-17 — BUSINESSTODAY: **Fortis Healthcare shares rise over 3% in early deals; here's why** — Fortis Healthcare share price, Fortis Healthcare shares, Fortis Healthcare news, Fortis Healthcare Ashok Vihar, Fortis Hospotel, SLJ Society, Ashok Vihar hospital, Delhi hospital, Fortis Healthcare agreement, healthcare stocks, hospital stocks, Fortis stock — [Source](https://www.businesstoday.in/markets/stocks/story/fortis-healthcare-shares-rise-in-early-deals-heres-why-556054-2026-09-17)
- 2026-09-17 — BUSINESS: **Fortis Healthcare climbs after signing 29-year healthcare services agreement** — Fortis Healthcare rose 2.94% to Rs 895.85 after the company signed definitive agreements with Seth Sunder Lal Jain Charitable Eye Hospital. — [Source](https://www.business-standard.com/markets/capital-market-news/fortis-healthcare-climbs-after-signing-29-year-healthcare-services-agreement-126091700292_1.html)
- 2026-09-17 — BUSINESS: **Stock Alert: Tempsens Instruments India, Infosys, Highway Infra, Alembic Pharma** — Shares of Inox Wind, Kaynes Technology India, Bandhan Bank and SAIL are banned from F&O trading on 17 September 2026. — [Source](https://www.business-standard.com/markets/capital-market-news/stock-alert-tempsens-instruments-india-infosys-highway-infra-alembic-pharma-126091700122_1.html)
- 2026-09-17 — BUSINESSTODAY: **Top stocks in news: Infosys, Rentomojo, Karamtara, ARCIL, Manipal Cards, Mazagon, Fortis, Steamhouse** — Stocks in news, Stocks in buzz, Stocks to buy, Stocks to watch, Infosys, Rentomojo, Karamtara Engineering, ARCIL, Manipal Cards, Mazagon Dock Shipbuilders, Fortis Healthcare, Steamhouse India, Tempsens Instruments, Skyways Air Services, Asset Reconstruction Company India (ARCIL), Alembic Pharmaceuticals, Manipal Payment & Identity Solutions, Juniper Hotels, Highway Infrastructure, Krsnaa Diagnostics, Gujarat Narmada Valley Fertilizers Chemicals, Venus Pipes & Tubes — [Source](https://www.businesstoday.in/markets/stocks/story/top-stocks-in-news-infosys-rentomojo-karamtara-arcil-manipal-cards-mazagon-fortis-steamhouse-556016-2026-09-17)
- 2026-09-17 — BUSINESS: **Stocks to watch: Mazagon Dock, JSW Energy, Highway Infra, Fortis & Infosys** — Stocks to watch today: LCC Projects, Karamtara Engineering, Manipal Payment, Rentomojo, Steamhouse India and Asset Reconstruction Company (India) are slated to list on the bourses today. — [Source](https://www.business-standard.com/markets/news/stocks-to-watch-september-17-mazagon-dock-jsw-energy-highway-infra-fortis-infosys-126091700085_1.html)
- 2026-09-17 — Economic Times: **Stocks in news: Infosys, Mazagon Dock, Fortis Healthcare, JSW Energy and Kalpataru Projects** — On September 16, Indian markets experienced a careful resurgence, with the Nifty and Sensex both moving upwards. This rebound was fueled by increased investments in banking and prominent stocks following a steep drop the previous day. Key players like Infosys and Mazagon Dock are under scrutiny due to recent corporate events. — [Source](https://economictimes.indiatimes.com/markets/stocks/news/stocks-in-news-infosys-mazagon-dock-fortis-healthcare-jsw-energy-and-kalpataru-projects/articleshow/134296725.cms)
- 2026-09-17 — The Hindu: **Buzzing stocks for Sept 17: Reliance, Infosys, Krsnaa, Mazagon Dock, Motilal Oswal, Granules,  Fine Organic Chem, Venus Pipes, Highway Infra** — Several Indian companies, including Reliance and Infosys, are making significant moves, from fundraising to new facilities, highlighting a dynamic shift in the corporate landscape — [Source](https://www.thehindubusinessline.com/markets/buzzing-stocks-for-sept-17-reliance-infosys-krsnaa-mazagon-dock-motilal-oswal-granules-fine-organic-chem-venus-pipes-highway-infra/article71475140.ece)
- 2026-09-16 — Mint: **Top stocks in focus tomorrow: Investors must watch Infosys, Mazagon Dock, shares on Thursday, 17 Sept | Triggers** — Indian stock market investors are set to monitor several companies on September 17, including Fortis Healthcare, Mazagon Dock Shipbuilders, and Infosys, due to significant business announcements and developments that may influence market activity. — [Source](https://www.livemint.com/market/top-stocks-in-focus-tomorrow-investors-must-watch-infosys-mazagon-dock-shares-on-thursday-17-sept-triggers-11789574580431.html)
- 2026-09-16 — The Hindu: **Fortis Healthcare moves Supreme Court against forensic audit order** — Fortis Healthcare has filed an SLP challenging the Delhi High Court’s forensic audit order in the Daiichi Sankyo enforcement proceedings. — [Source](https://www.thehindubusinessline.com/companies/fortis-healthcare-files-slp-against-forensic-audit-order-in-daiichi-sankyo-case/article71473603.ece)
- 2026-09-16 — MONEYCONTROL: **Fortis Healthcare moves Supreme Court against forensic audit order in Daiichi Sankyo matter** — Fortis Healthcare, Fortis moves supreme court, Daiichi Sankyo matter, Special Leave Petition — [Source](https://www.moneycontrol.com/news/india/fortis-healthcare-moves-supreme-court-against-forensic-audit-order-in-daiichi-sankyo-matter-14031417.html)
- 2026-09-16 — CNBC-TV18: **Fortis Healthcare signs 29-year pact for 400+ bed super speciality hospital in Delhi** — Shares of Fortis Healthcare Ltd ended at ₹868.50, down by ₹10.50, or 1.19%, on the BSE. — [Source](https://www.cnbctv18.com/market/stocks/fortis-healthcare-share-price-signs-29-year-pact-for-400-bed-super-speciality-hospital-in-delhi-19992166.htm)
- 2026-09-16 — CNBC-TV18: **Stocks to Watch for September 17: Fortis Healthcare, Infosys, Mazagon Dock, Kalpataru Projects and more** — From Krsnaa Diagnostics executing a 15-year concession agreement with the Punjab Health Systems Corporation to Juniper Hotels approving the proposed acquisition of the operating Novotel Imagicaa hotel in Khopoli, Maharashtra, here are the stocks to track ahead of Thursday’s trading session. — [Source](https://www.cnbctv18.com/photos/market/stocks-to-watch-for-september-17-fortis-healthcare-infosys-mazagon-dock-kalpataru-projects-and-more-19992119.htm)
- 2026-09-16 — CNBC-TV18: **Fortis Healthcare moves Supreme Court to stop forensic audit of IHH takeover** — Fortis Healthcare has challenged a Delhi High Court order for a forensic audit of IHH’s acquisition, saying the listed company should not be held responsible for its former promoters’ personal dispute with Daiichi. — [Source](https://www.cnbctv18.com/business/companies/fortis-healthcare-moves-supreme-court-to-stop-forensic-audit-of-ihh-takeover-19992128.htm)
- 2026-09-16 — NEWS.WEBINDIA123.COM: **Fortis Healthcare moves SC against Delhi HC order directing forensic audit, says non-party company cannot be made liable for erstwhile promoters acts** — Fortis Healthcare Limited has approached the Supreme Court challenging the Delhi High Courts August 31 order in the enforcement proceedings relating to Daiichi Sankyos arbitral award against former Fortis promoters Malvinder Mohan Singh and Shivinder Mohan Singh and their related entities. — [Source](https://news.webindia123.com/news/articles/india/20260916/4499362.html)
- 2026-09-16 — Economic Times: **Fortis Healthcare moves Supreme Court against Delhi HC forensic audit order; Axis Bank may follow** — In a significant legal move, Fortis Healthcare has appealed to the Supreme Court against a Delhi High Court decision requiring a forensic audit of its dealings with IHH Healthcare. This case is part of larger litigation concerning Daiichi Sankyo Company. IHH Healthcare, based in Malaysia, maintains a controlling interest in Fortis. Notably, Axis Bank is also gearing up to challenge the High Court's ruling. — [Source](https://economictimes.indiatimes.com/news/india/fortis-healthcare-moves-supreme-court-against-delhi-hc-forensic-audit-order-axis-bank-may-follow/articleshow/134279742.cms)
- 2026-09-15 — Economic Times: **Yes Bank challenges HC order on forensic audit of Fortis Healthcare share sale to IHH Healthcare** — Yes Bank has approached the Supreme Court challenging a recent Delhi High Court directive. The court ordered a forensic audit into the sale of Fortis Healthcare shares. Yes Bank argues it was not a party to the original arbitration proceedings. However, the bank does not oppose auditing Fortis and its former promoters. It will provide relevant transaction information within legal limits. — [Source](https://economictimes.indiatimes.com/industry/banking/finance/banking/yes-bank-challenges-delhi-hc-ruling-on-forensic-audit-of-fortis-healthcare-share-sale-to-ihh-healthcare/articleshow/134268169.cms)
- 2026-09-11 — Economic Times: **Japan court dismisses IHH subsidiary Northern TK Venture's damage claims against Daiichi Sankyo** — NTK, a subsidiary of IHH Healthcare Berhad had earlier filed a claim at the Tokyo District Court seeking damages from Daiichi Sankyo, alleging that the Japanese firm had obstructed NTK's efforts to complete its open offers to acquire shares in Fortis Healthcare Limited and its step-down subsidiary, Fortis Malar Hospitals Limited. — [Source](https://economictimes.indiatimes.com/industry/healthcare/biotech/healthcare/japan-court-dismisses-ihh-subsidiary-northern-tk-ventures-damage-claims-against-daiichi-sankyo/articleshow/134048690.cms)
- 2026-09-08 — Mint: **Which mid-cap stocks are fund managers chasing? Federal Bank leads the list, Swiggy enters top 10 | Mint** — Fund managers are reshuffling their mid-cap bets, with some stocks gaining traction. The July portfolio disclosures of actively managed funds reveal the changing favourites and offer clues about where institutional interest is building. — [Source](https://www.livemint.com/money/personal-finance/which-mid-cap-stocks-are-fund-managers-chasing-federal-bank-leads-the-list-swiggy-enters-top-10-11788883112167.html)
- 2026-09-08 — Mint: **Buy Fortis Healthcare shares, says PL Capital; check target price, stock performance** — Stock to buy today: Fortis Healthcare share price outlook is unlikely to be impacted by the probe directed by the Delhi HC last week, according to PL Capital report. The hospital chain stock is poised for a double digit growth in the long-term. — [Source](https://www.livemint.com/market/stock-market-news/buy-fortis-healthcare-shares-says-pl-capital-check-target-price-stock-performance-11788855203728.html)
- 2026-09-07 — Economic Times: **Asian Paints names former JPMorgan exec Leo Puri as next chairman** — As part of its strategic growth plan, Asian Paints has selected Leo Puri to serve as chairman-designate starting January 2027, taking over from R. Seshasayee. This leadership change comes at a critical time as the company confronts formidable competition from well-funded new entrants aiming to capture market share in the decorative paints space, putting pressure on profit margins. — [Source](https://economictimes.indiatimes.com/industry/cons-products/paints/asian-paints-names-former-jpmorgan-exec-leo-puri-as-next-chairman/articleshow/133875203.cms)
- 2026-09-07 — MONEYCONTROL: **Buy Fortis Healthcare; target of Rs 1075: ICICI Securities** — ICICI Securities, Fortis Healthcare, buy, Recommendations — [Source](https://www.moneycontrol.com/news/business/stocks/buy-fortis-healthcare-target-of-rs-1075-icici-securities-2-14024263.html)
- 2026-09-07 — MONEYCONTROL: **Buy Fortis Healthcare; target of Rs 1130: Motilal Oswal** — Motilal Oswal, Fortis Healthcare, buy, Recommendations — [Source](https://www.moneycontrol.com/news/business/stocks/buy-fortis-healthcare-target-of-rs-1130-motilal-oswal-14024141.html)
- 2026-09-07 — MONEYCONTROL: **Buy Fortis Healthcare; target of Rs 1050: Prabhudas Lilladher** — Prabhudas Lilladher, Fortis Healthcare, buy, Recommendations — [Source](https://www.moneycontrol.com/news/business/stocks/buy-fortis-healthcare-target-of-rs-1050-prabhudas-lilladher-2-14024013.html)

## Business profile

**Strategic vision:** Integrated healthcare delivery services provider in India.

### Business segments
- **Diagnostic Services:** Agilus Diagnostics provides diagnostic services as a significant part of Fortis's offering.
- **Hospital Operations:** Fortis operates a network of hospitals across India, offering a range of medical facilities and specialized care.

### Competitive strengths
- Network of hospitals and diagnostic services
- Integrated healthcare delivery model

## Related stocks

- [ABBOTINDIA (Healthcare)](https://faxioms.com/stocks/abbotindia) — +5.50%
- [ACUTAAS (Healthcare)](https://faxioms.com/stocks/acutaas) — +3.86%
- [AJANTPHARM (Healthcare)](https://faxioms.com/stocks/ajantpharm) — +1.61%
- [ALKEM (Healthcare)](https://faxioms.com/stocks/alkem) — +0.14%
- [ANTHEM (Healthcare)](https://faxioms.com/stocks/anthem) — -0.35%

## Freshness and sources

- Data as of: 2026-09-18
- Source: Faxioms public stock analysis API

Canonical: https://faxioms.com/stocks/fortis
Markdown representation: https://faxioms.com/stocks/fortis?render=md